Elite in Hemophilia B

Amit C. Nathwani

98 Chenies Mews, WC1E 6HX, 
London, ENG, GB 
Elite in Hemophilia B
98 Chenies Mews, WC1E 6HX, 
London, ENG, GB 
OverviewLocationsClinical Research

Overview

Amit Nathwani practices in London, United Kingdom. Mr. Nathwani is rated as an Elite expert by MediFind in the treatment of Hemophilia B. His top areas of expertise are Hemophilia B, Blood Clots, Hemophilia A, and Chronic Lymphocytic Leukemia (CLL).

His clinical research consists of co-authoring 90 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 32 articles and participated in 1 clinical trial in the study of Hemophilia B.

Gender
Male

Locations

98 Chenies Mews, WC1E 6HX, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open Label Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector (scAAV 2/8-LP1-hFIXco) For Gene Transfer in Hemophilia B
An Open Label Dose-Escalation Study Of A Self Complementary Adeno-Associated Viral Vector (scAAV 2/8-LP1-hFIXco) For Gene Transfer in Hemophilia B
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2025
Intervention Type: Genetic, Drug
Study Drug: scAAV2/8-LP1-hFIXco
Study Phase: Phase 1
GO-8: Gene Therapy for Haemophilia A Using a Novel Serotype 8 Capsid Pseudotyped Adeno-associated Viral Vector Encoding Factor VIII-V3
GO-8: Gene Therapy for Haemophilia A Using a Novel Serotype 8 Capsid Pseudotyped Adeno-associated Viral Vector Encoding Factor VIII-V3
Enrollment Status: Active_not_recruiting
Publish Date: March 05, 2025
Intervention Type: Biological
Study Drug: AAV2/8-HLP-FVIII-V3
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

90 Total Publications

AAV Gene Therapy in Severe Hemophilia B. Reply.
AAV Gene Therapy in Severe Hemophilia B. Reply.
Journal: The New England journal of medicine
Published: August 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Nathwani's expertise for a condition
ConditionClose
View All 10 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile